Cargando…
Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic
It is unclear whether molnupiravir has a beneficial effect on vaccinated patients infected with the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We here evaluated the efficacy of molnupiravir in patients with mild-to-moderate coronavirus disease 2019 (COVID-19) du...
Ejemplares similares
-
Real-world clinical outcomes of treatment with casirivimab-imdevimab among patients with mild-to-moderate coronavirus disease 2019 during the Delta variant pandemic
por: Suzuki, Yasuhito, et al.
Publicado: (2022) -
Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19
por: Shibata, Yoko, et al.
Publicado: (2023) -
Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer
por: Sato, Yuki, et al.
Publicado: (2022) -
Clinical effect of early administration of tocilizumab following the initiation of corticosteroid therapy for patients with COVID-19()
por: Kawamata, Takaya, et al.
Publicado: (2022) -
Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study
por: Sato, Suguru, et al.
Publicado: (2021)